Impacto da depressão na qualidade de vida e na adesão a levodopa em pacientes com doença de Parkinson

Impacto da depressão na qualidade de vida e na adesão a levodopa em pacientes com doença de Parkinson

Considerada universal, a doença de Parkinson (DP) ocupa a segunda posição entre as doenças neurodegenerativas mais comuns em idosos. A depressão é a comorbidade psiquiátrica mais comumente associada à esta doença e tem sido apontada repetidamente como a principal determinante da piora da qualidade d...

Full description

Bibliographic Details
Main Author:	Marchi, Katia Colombo
Other Authors:	Tirapelli, Carlos Renato
Format:	Others
Language:	pt
Published:	Biblioteca Digitais de Teses e Dissertações da USP 2012
Subjects:	Adesão à Medicação Depressão Depression Doença de Parkinson Levodopa Medication Adherence Parkinson Disease Qualidade de vida Quality of Life
Online Access:	http://www.teses.usp.br/teses/disponiveis/22/22131/tde-28022012-141605/

Similar Items

Impacto da depressão na qualidade de vida e na adesão a levodopa em pacientes com doença de Parkinson
by: Katia Colombo Marchi
Published: (2012)

Adesão à medicação em pacientes com doença de Parkinson atendidos em ambulatório especializado Adherence to medication among patients with Parkinson's disease treated at a specialized outpatient unit
by: José Alexandre de Souza Crippa, et al.
Published: (2013-03-01)

Discinesias induzidas por levodopa em 176 pacientes com doença de Parkinson Levodopa-induced dyskinesias in 176 parkisonian patients
by: Maria Sheila G. Rocha, et al.
Published: (1995-12-01)

Pain in Parkinson's disease Dor na doença de Parkinson
by: Grace Helena Letro, et al.
Published: (2009-09-01)

Sleep disturbances in drug naïve Parkinson′s disease (PD) patients and effect of levodopa on sleep
by: Teresa Ferreira, et al.
Published: (2014-01-01)

Avaliação dos Níveis de Ansiedade em Pacientes com Doença de Parkinson em uso de Levodopa
by: Carolina Melo Cândido de Paula
Published: (2011)

Avaliação dos Níveis de Ansiedade em Pacientes com Doença de Parkinson em uso de Levodopa
by: Paula, Carolina Melo Cândido de
Published: (2011)

Levodopa for treatment of parkinson’s disease
by: M. Petraru, et al.
Published: (2011-09-01)

Method of Levodopa Response Calculation Determines Strength of Association With Clinical Factors in Parkinson Disease
by: Marcus Pieterman, et al.
Published: (2018-05-01)

Verificação dos efeitos da Levodopa na deglutição de pacientes com doença de Parkinson
by: Douglas Monteiro, et al.
Published: (2014-03-01)

A systematic review and integrative approach to decode the common molecular link between levodopa response and Parkinson’s disease
by: Debleena Guin, et al.
Published: (2017-09-01)

Dynamics of levodopa-therapy in patients with Parkinson’s disease afterunilateral pallidotomy
by: V.I. Tsymbaliuk, et al.
Published: (2018-12-01)

Thrombocytopenia Associated with Levodopa Treatment
by: Ku-Eun Lee, et al.
Published: (2013-05-01)

Mythology of Parkinson’s disease: from levodopa phobia to dopamine agonist phobia
by: O. S. Levin, et al.
Published: (2020-12-01)

Efeitos comportamentais do uso prolongado de levodopa em pacientes com doença de Parkinson
by: Rosal, Veronesia Maria de Sena
Published: (2016)

Serial macro-architectural alterations with levodopa in Parkinson′s disease: Polysomnography (PSG)-based analysis
by: Sanju P Joy, et al.
Published: (2015-01-01)

Effect of ganglioside and levodopa combined therapy on Parkinson's Disease
by: Qiong Li, et al.
Published: (2016-12-01)

Influência da levodopa sobre a fase oral da deglutição em pacientes com Doença de Parkinson Influence of levodopa on the oral phase of swallowing in patients with Parkinson's disease
by: Renata Mancopes, et al.
Published: (2013-01-01)

Combined and Sequential Treatment with Deep Brain Stimulation and Continuous Intrajejunal Levodopa Infusion for Parkinson’s Disease
by: Daniël van Poppelen, et al.
Published: (2021-06-01)

Efeito da levodopa na mecânica coclear e no sistema auditivo eferente de indivíduos com doença de Parkinson
by: Marcia da Silva Lopes, et al.
Published: (2019-02-01)

Predictors of levo-dopa induced dyskinesias in Parkinson's disease
by: R T Athulya, et al.
Published: (2020-01-01)

Differences in Levodopa Response for Progressive and Non-Progressive Micrographia in Parkinson's Disease
by: Poonam Zham, et al.
Published: (2021-05-01)

Ação da levodopa e sua influência na voz e na fala de indivíduos com doença de Parkinson The action of levodopa and its influence on voice and speech of patients with Parkinson desease
by: Luciana Lemos de Azevedo, et al.
Published: (2009-01-01)

Levodopa-Responsive Benign Tremulous Parkinsonism
by: Osamu Kano, et al.
Published: (2013-08-01)

Farmacogenética da levodopa na doença de Parkinson : estudo de polimorfismos nos genes da COMT, MAO-B e DAT
by: Schuh, Artur Francisco Schumacher
Published: (2012)

Farmacogenética da levodopa na doença de Parkinson : estudo de polimorfismos nos genes da COMT, MAO-B e DAT
by: Schuh, Artur Francisco Schumacher
Published: (2012)

Farmacogenética da levodopa na doença de Parkinson : estudo de polimorfismos nos genes da COMT, MAO-B e DAT
by: Schuh, Artur Francisco Schumacher
Published: (2012)

Quality of life scale in parkinson's disease PDQ-39 - (Brazilian Portuguese version) to assess patients with and without levodopa motor fluctuation Escala para qualidade de vida na doença de Parkinson - PDQ 39 (versão do Português falado no Brasil) como instrumento para avaliação de pacientes com e sem flutuação motora decorrente da levodopa
by: Renata Guzzo Souza, et al.
Published: (2007-09-01)

Working memory in Parkinson's disease patients: clinical features and response to levodopa Memória de trabalho em pacientes com doença de Parkinson: características clínicas e resposta a levodopa
by: Rogério Beato, et al.
Published: (2008-06-01)

Therapeutic Effect of Levodopa/Carbidopa/Entacapone on Sleep Disturbance in Patients with Parkinson’s Disease
by: Kye Won Park, et al.
Published: (2020-09-01)

Levodopa in the treatment of Parkinson’s disease: an old drug still going strong
by: Werner Poewe, et al.
Published: (2010-08-01)

Prosody and levodopa in Parkinsons disease
by: Luciana Lemos de Azevedo, et al.
Published: (2013-11-01)

Effect of levodopa on interleukin-15 and RANTES circulating levels in patients affected by Parkinson's disease
by: Sebastiano Gangemi, et al.
Published: (2003-01-01)

Effect of Rectal Levodopa Administration: A Case Report
by: Jolanda M.J. Vogelzang, et al.
Published: (2015-10-01)

Pharmacokinetics of Levodopa before and after Gastrointestinal Resection in Parkinson's Disease
by: Hiroshi Nagayama, et al.
Published: (2015-09-01)

Less Pulsatile Levodopa Therapy (6 Doses Daily) Is Associated with a Reduced Incidence of Dyskinesia
by: Mark M. Lin, et al.
Published: (2019-01-01)

AVALIAÇÃO CLÍNICA DA DOR NO PERÍODO DE WEARING OFF DE PACIENTES COM DOENÇA DE PARKINSON EM TRATAMENTO COM LEVODOPA
by: Blood, Marcelo Rezende Young
Published: (2017)

Experience in using levodopa-benserazide
by: Elena Anatolyevna Katunina, et al.
Published: (2015-10-01)

The human experience with intravenous levodopa
by: Shan H Siddiqi, et al.
Published: (2016-01-01)

Levodopa/carbidopa/entacapone versus levodopa/dopa-decarboxyiase inhibitor for the treatment of Parkinson's disease: systematic review, meta-analysis, and economic evaluation
by: Yi ZM, et al.
Published: (2018-04-01)